| North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I … A Alikhan, C Sayed, A Alavi, R Alhusayen, A Brassard, C Burkhart, ... Journal of the American Academy of Dermatology 81 (1), 76-90, 2019 | 474 | 2019 |
| Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project A Garg, E Neuren, D Cha, JS Kirby, JR Ingram, GBE Jemec, S Esmann, ... Journal of the American Academy of Dermatology 82 (2), 366-376, 2020 | 193 | 2020 |
| Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations A Garg, N Malviya, A Strunk, S Wright, A Alavi, R Alhusayen, A Alikhan, ... Journal of the American Academy of Dermatology 86 (5), 1092-1101, 2022 | 120 | 2022 |
| Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial S Glatt, GBE Jemec, S Forman, C Sayed, G Schmieder, J Weisman, ... JAMA dermatology 157 (11), 1279-1288, 2021 | 94 | 2021 |
| Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice LAV Orenstein, TV Nguyen, G Damiani, C Sayed, GBE Jemec, I Hamzavi Dermatology 236 (5), 393-412, 2020 | 64 | 2020 |
| Target molecules for future hidradenitis suppurativa treatment CC Zouboulis, JW Frew, EJ Giamarellos‐Bourboulis, GBE Jemec, ... Experimental Dermatology 30, 8-17, 2021 | 43 | 2021 |
| Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa AN Oskardmay, JA Miles, CJ Sayed Journal of the American Academy of Dermatology 81 (3), 702-708, 2019 | 42 | 2019 |
| Non-response to interleukin-1 antagonist canakinumab in two patients with refractory pyoderma gangrenosum and hidradenitis suppurativa NZ Sun, T Ro, P Jolly, CJ Sayed The Journal of Clinical and Aesthetic Dermatology 10 (9), 36, 2017 | 38 | 2017 |
| Intralesional triamcinolone may not be beneficial for treating acute hidradenitis suppurativa lesions: a double-blind, randomized, placebo-controlled trial K Fajgenbaum, L Crouse, L Dong, D Zeng, C Sayed Dermatologic Surgery 46 (5), 685-689, 2020 | 32 | 2020 |
| Development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa T Tzellos, KR van Straalen, A Kyrgidis, A Alavi, N Goldfarb, W Gulliver, ... Journal of the European Academy of Dermatology and Venereology 37 (2), 395-401, 2023 | 22 | 2023 |
| Hemorrhagic bullae of the oral mucosa K Paci, KM Varman, CJ Sayed JAAD case reports 2 (6), 433-435, 2016 | 20 | 2016 |
| Identifying unmet care needs and important treatment attributes in the management of hidradenitis suppurativa: a qualitative interview study D Willems, M Hiligsmann, HH van der Zee, CJ Sayed, SMAA Evers The Patient-Patient-Centered Outcomes Research, 1-12, 2021 | 17 | 2021 |
| Bimekizumab in patients with moderate-to-severe hidradenitis suppurativa: 48-week efficacy and safety from BE HEARD I & II, two phase 3, randomized, double-blind, placebo … AB Kimball, CC Zouboulis, C Sayed AAD Late-Breaking Research Program, 2023 | 16 | 2023 |
| PD‐L1 and LAG‐3 expression in advanced cutaneous squamous cell carcinomas S Wu, NA Slater, CJ Sayed, PB Googe Journal of Cutaneous Pathology 47 (10), 882-887, 2020 | 16 | 2020 |
| Hidradenitis suppurativa foundation Women's health subcommittee CJ Sayed, JL Hsiao, MM Okun Clinical epidemiology and management of hidradenitis suppurativa. Obstet …, 2021 | 13 | 2021 |
| Clinical epidemiology and management of hidradenitis suppurativa CJ Sayed, JL Hsiao, MM Okun Obstetrics & Gynecology 137 (4), 731-746, 2021 | 13 | 2021 |
| Surgery is an essential aspect of managing patients with hidradenitis suppurativa MMM Gonzalez, CJ Sayed Journal of the American Academy of Dermatology 83 (3), 979-980, 2020 | 12 | 2020 |
| Patient impressions and outcomes after clinic-based hidradenitis suppurativa surgery S Ravi, JA Miles, C Steele, MK Christiansen, CJ Sayed JAMA dermatology 158 (2), 132-141, 2022 | 11 | 2022 |
| Molecular genetic dissection of inflammatory linear verrucous epidermal naevus leads to successful targeted therapy M Riachi, S Polubothu, P Stadnik, C Hughes, SB Martin, CR Charman, ... The Journal of Investigative Dermatology 141 (12), 2979, 2021 | 11 | 2021 |
| Golimumab for the Treatment of Hidradenitis Suppurativa in Patients with Previous TNF-α Treatment Failure. MDM Melendez-Gonzalez, J Hamad, C Sayed The Journal of Investigative Dermatology 141 (12), 2975-2979, 2021 | 10 | 2021 |
